A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

Clinical trial NCT05310071 · TERMINATED

Trial details

NCT number: NCT05310071
Sponsor: Biogen
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2022-06-02
Primary completion: 2024-08-12
Enrollment: 1027

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.